чем лечить осипший голос и кашель у ребенка до года
Главное меню:
Интересное
чем лечить осипший голос и кашель у ребенка до года, Conceptualizing stigma in contexts of pregnancy and opioid misuse: A , Barriers to women's disclosure of and treatment for substance use , Substance Use in Pregnancy: Identifying Stigma and Improving Care, Mothers & babies Drug use during pregnancy - Australian Institute of , Pregnancy- and parenting-related barriers to receiving medication for , “My Addiction Doesn’t Define Me”—Experiences of Stigma - MDPI, Substance use during pregnancy, birth and the postnatal period.
Check supported browsers Your technical details and browser version: Request ID: 971852aa2eb6cc74-IAD IP: 64.71.32.82 UTC time: 2025-08-19T08:36:22+00:00 Browser: Mozilla/5.0 (Windows NT 6.1) AppleWebKit/536.11 (KHTML, like Gecko) Chrome/20.0.1132.47 Safari/536.11 About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyCookies are used by this site. Cookie SettingsAll content on this site: Copyright © 2024 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. , Methods We triangulate in-depth interviews with 28 women with histories of opioid misuse who were pregnant or recently gave birth and 18 healthcare providers in Ohio. Thematic analysis examined how stigma operates across contexts of care., These include various support groups or social services often managed by small community organisations, opioid agonist treatment with methadone and buprenorphine, and specialist alcohol and drug services within public hospitals [17], however little is known about the barriers experienced by women who use substances during pregnancy in relation .
In a retrospective cohort study from Australia, which com-pared obstetric outcomes in pregnant people treated with naltrexone implant versus oral methadone versus sublin-gual buprenorphine, naltrexone had a significant increase in birth rate compared to opioid agonist treatment and control with a similar rate of complication as compared to , This web page provides links to information and tools for midwives and other maternity clinicians on drug use and pregnancy and to support services that may be beneficial for their clients., Objectives: This study adds to the extant literature by elucidating the pregnancy- and parenting-related barriers women face when initiating or continuing medication for opioid use disorder, specifically. Design: This study is based on qualitative semi-structured interviews., Opioid use in women has increased by 300% since 1999, and opioid use disorder among pregnant women has quadrupled. The stigma of substance use disorder is a significant barrier to treatment, especially among women. The purpose of this study was to explore the experiences and perceptions of stigma among mothers and the underlying themes. (1) Background: To understand the stigmatization of women , Opioid replacement therapies such as methadone and buprenorphine decrease illicit opioid use during pregnancy and improve pregnancy outcomes. Ongoing treatment with opioid replacement therapies should be supported as a means to reduce illicit substance use beyond the pregnancy, extrapolating from very well-established evidence in non-pregnant , Background Clinical guidelines in the United States (U.S.) recommend a patient-centered approach to healthcare for pregnant people with substance use disorders (SUD); however, pregnant people with SUD often describe experiencing stigmatization and shame when seeking prenatal care. We explored the perspectives of pregnant and parenting people engaged with SUD treatment regarding their .